| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/22/2004 | WO2004029229A3 Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands |
| 07/22/2004 | WO2004027044A3 Triplex hairpin ribozyme |
| 07/22/2004 | WO2004026238A8 Immunotherapeutic compositions and methods for the treatment of moderately to well-differentiated cancers |
| 07/22/2004 | WO2004024884A3 Syts as modifiers of the p21 pathway and methods of use |
| 07/22/2004 | WO2004022759A3 Method for improving corn starch extractability |
| 07/22/2004 | WO2004021977A3 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 07/22/2004 | WO2004020654A3 Solid phase based nucleic acid assays combining high affinity and high specificity |
| 07/22/2004 | WO2004016073A3 Wheat plants having increased resistance to imidazolinone herbicides |
| 07/22/2004 | WO2004015058A3 Nephritis treatment by gene therapy |
| 07/22/2004 | WO2004014936A3 Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof |
| 07/22/2004 | WO2004013290A3 Compositions and methods for molecular biology |
| 07/22/2004 | WO2004009822A3 Use of specific myb genes for the production of transgenic plants tolerant to biotic and abiotic stresses |
| 07/22/2004 | WO2004007547A3 Truncated tau proteins |
| 07/22/2004 | WO2004005529A3 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 07/22/2004 | WO2004005517A3 L-amidase from rhizobium huautlense |
| 07/22/2004 | WO2003097158A3 Electroporation-mediated transfection of the salivary gland |
| 07/22/2004 | WO2003095973A3 Nanoparticle probes with raman spectroscopic fingerprints for analyte detection |
| 07/22/2004 | WO2003093471A8 Novel 88 phage vectors |
| 07/22/2004 | WO2003089452B1 Compositions and methods for regulation of plant gamma-tocopherol methyltransferase |
| 07/22/2004 | WO2003085084A3 Hepatitis c virus sub-genomic replicons |
| 07/22/2004 | WO2003082184A3 Truncated lysostaphin molecule with enhanced staphylolytic activity |
| 07/22/2004 | WO2003081202A3 Bioconjugate-nanoparticle probes |
| 07/22/2004 | WO2003077863A3 Method for overexpression of zwitterionic polysaccharides |
| 07/22/2004 | WO2003075849A3 Composition and method for enhancing immune response |
| 07/22/2004 | WO2003075843A3 Multiple and multivalent dna vaccines in ovo |
| 07/22/2004 | WO2003064680A3 Light activated gene transduction using ultraviolet light for cell targeted gene delivery |
| 07/22/2004 | WO2003062423A3 Method for inhibiting the expression of a target gene resulting from a chromosome aberration |
| 07/22/2004 | WO2003061596A3 Methods and reagents for generating chimeric serum peptide carri ers |
| 07/22/2004 | WO2003059949A3 A protein that mediates angiogenesis and tumour growth inhibition, its cdna, alone or in complex with an expression vector |
| 07/22/2004 | WO2003059148A3 Gene expression profiles in stomach cancer |
| 07/22/2004 | WO2003053215A3 Diagnosis prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling |
| 07/22/2004 | WO2003052078A3 Insect g protein-coupled receptor genes and uses thereof |
| 07/22/2004 | WO2003049691A3 Antisense modulation of pctaire protein kinase 1 expression |
| 07/22/2004 | WO2003031583A3 Generation of virus-like particles by vsv |
| 07/22/2004 | WO2003026417A3 Method of increasing expression of heterologous proteins in plants |
| 07/22/2004 | WO2003022869A3 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof |
| 07/22/2004 | WO2003014299A3 SPHKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 07/22/2004 | WO2003010506A3 Combined electronic-and photonic-based hybridation assay |
| 07/22/2004 | WO2003010326A3 Parallel, antiparallel, homologous or complementary binding of nucleic acids |
| 07/22/2004 | WO2003000735A3 Nucleic acids encoding olfactory receptors |
| 07/22/2004 | WO2002101076A3 Methods for targeted expression of therapeutic nucleic acid |
| 07/22/2004 | WO2002099048A3 LIMKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 07/22/2004 | WO2002079410A3 Glucan chain length domains |
| 07/22/2004 | WO2002074239A3 Compositions and methods for the treatment and clinical remission of psoriasis |
| 07/22/2004 | WO2002059281A3 High level cytokine production with enhanced cell viability |
| 07/22/2004 | US20040143874 Inducible site-specific recombination for the activation and removal of transgenes in transgenic plants |
| 07/22/2004 | US20040143873 Comprises nucleotide sequences coding enzyme inhibitor for transformation into plants and reducing activity of glutamine syhthetase in senescing leaves; nitrogen reduction in plant root system |
| 07/22/2004 | US20040143872 Genetic control of organ abscission |
| 07/22/2004 | US20040143871 Nucleotide sequences coding galactosyltransferase and mannan synthase for transforming monocot/dicots and production of gums in transgenic plants; tissue engineering |
| 07/22/2004 | US20040143870 Comprises nucleotide sequences coding polypeptide associated with branch migration during genetic exchanged for use as for use as gene transfer enhancement tool during genetic engineering |
| 07/22/2004 | US20040143869 Using antibodies to identify modulators of glutathione s-transferase; genetic engineering and generating herbicide resistant plants |
| 07/22/2004 | US20040143868 Root promoter sequences for use as gene expression tools in plants |
| 07/22/2004 | US20040143867 High level production of p-hydroxybenzoic acid in green plants |
| 07/22/2004 | US20040143865 Transgenic fish models for identifying inhibitors of neovascularization; antitumor/antiproliferative agents; wound healing agents |
| 07/22/2004 | US20040143864 Chimeric gene constructs for generation of fluorescent transgenic ornamental fish |
| 07/22/2004 | US20040143863 Expression vectors comprising bone morphogenic protein for use in the transformation of osteoblast and controlling propagation and enrichment of stem cells in vivo |
| 07/22/2004 | US20040143862 Mammalian embryonic stem cell wherein the lecithin:cholesterol acyltransferase-like lysophospholipase gene is inactivated for use as model for identifying modulators for treatment of arteriosclerosis |
| 07/22/2004 | US20040143861 Using satellite artificial chromosome (SATAC) as gene therapeutic tool to transform and propagate transgenic cells and treat metabolic disorders |
| 07/22/2004 | US20040143859 Novel proteins and methods for producing the proteins |
| 07/22/2004 | US20040143857 Erythropoietin analog-human serum albumin fusion |
| 07/22/2004 | US20040143854 Using inducible vectors to transform cells and propagate organism for use as drug screening tools; phenotyping |
| 07/22/2004 | US20040143113 Comprises nucleotide sequences coding integrin for identifying modulators which can be utilized to treat and diagnosis cancer; cosmetic; nutraceuticals |
| 07/22/2004 | US20040143109 Nucleotide sequences for diagnosing periodontal diseases |
| 07/22/2004 | US20040143102 Ligand polypeptide for identifying modulators for treatment of nervous system disorders, schizophrenia and arthritis |
| 07/22/2004 | US20040143101 Immunoglobulin construct containing anti-mucin variable domain sequences for eliciting an anti-idiotype anti-tumor response |
| 07/22/2004 | US20040143098 Comprises nucleotide sequences coding polypeptides for use in the transformation and generation of drought, heat, freeze and disease resistant plants |
| 07/22/2004 | US20040143097 Expression vectors coding interleukin polypeptide for use in prevention and treatment of infections, autoimmune, and cell proliferative disease and for stimulating the proliferation of platelets; wound healing agents |
| 07/22/2004 | US20040143096 Interferon for use in the treatment of infections, autoimmune, nervous system and viral diseases and for restoring normal blood cell levels in patients suffering from anemia or receiving chemotherapy for cancer |
| 07/22/2004 | US20040143095 for treating high body temperature, appetite dysfunction, congestive heart failure, vascular disease, stress and anxiety; angiogenesis inhibitors; genetic engineering |
| 07/22/2004 | US20040143092 Regulation of human dorsal root receptor-like g protein-coupled receptor |
| 07/22/2004 | US20040142946 Modified nucleosides and nucleotides and use thereof |
| 07/22/2004 | US20040142901 Production of pancreatic islet cells and delivery of insulin |
| 07/22/2004 | US20040142899 Compositions and methods for enhanced biostability and altered biodistribution of oligonucleotides in mammals |
| 07/22/2004 | US20040142898 also known as GLI-related finger protein and GLI Kruappel family member; may be associated with the regulation of a signaling pathway involved in the progression of lung cancer or the acquisition of resistance to platinum drugs |
| 07/22/2004 | US20040142896 High efficacy antisense RIalpha PKA poly-DNP oligoribonucleotides |
| 07/22/2004 | US20040142895 Nucleic acid-based modulation of gene expression in the vascular endothelial growth factor pathway |
| 07/22/2004 | US20040142893 Methods for treating and preventing vascular disease |
| 07/22/2004 | US20040142892 expression cassettes comprising a eukaryotic promoter and a first RNA polymerase promoter operably linked to a nucleic acid encoding a secretable RNA polymerase comprising a RNA polymerase and a secretion domain, and internal ribosome entry site |
| 07/22/2004 | US20040142888 Modulators of RabGGT and methods of use thereof |
| 07/22/2004 | US20040142886 use of vascular endothelial growth factor to enhance smooth muscle cell proliferation and to treat diseases associated with reduced smooth muscle cell proliferation |
| 07/22/2004 | US20040142885 host cell; gene therapy |
| 07/22/2004 | US20040142884 Compositions and methods for the acceleration of protein secretion dynamics |
| 07/22/2004 | US20040142866 Derivatives of the insulinotropic peptide exendin-4 and methods of production thereof |
| 07/22/2004 | US20040142863 modified aggrecanases, nucleotides encoding such enzymes, and processes for producing these enzymes with improved stability; treatment of osteoarthritis |
| 07/22/2004 | US20040142861 at least one genetically-engineered growth factor, at least one genetically-engineered antioxidant, at least one genetically-engineered extracellular matrix component |
| 07/22/2004 | US20040142837 Alkaline protease |
| 07/22/2004 | US20040142493 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 07/22/2004 | US20040142478 Expression vector comprising saccharomyces regulatory sequences for controlling heterologous and homologous gene expression; genetic engineering protein translation |
| 07/22/2004 | US20040142477 Expression vector comprising antisense or inhibitory RNA sequences for use in increasing phyotene concentration in plants; tissue engineering |
| 07/22/2004 | US20040142476 Organellar targeting of RNA and its use in the interruption of environmental gene flow |
| 07/22/2004 | US20040142475 Delivery systems for bioactive agents |
| 07/22/2004 | US20040142473 Means and methods for fibroblast-like or macrophage-like cell transduction |
| 07/22/2004 | US20040142472 Gene delivery vectors with cell type specificity for primary human chondrocytes |
| 07/22/2004 | US20040142471 Preparing membrane receptors from extracellular baciloviruses |
| 07/22/2004 | US20040142470 Recombinase-based system for construction of adenovirus vectors |
| 07/22/2004 | US20040142467 Regeneration of both plant tissues and transgenic plant tissues using a new plant hormone, 5-bromoindole-3-acetic acid |
| 07/22/2004 | US20040142459 Device and method for thermal cycling |
| 07/22/2004 | US20040142456 Transgenic saccharomyces expressing xylulokinase for use in fermentation ethanol; conversion of cellullosic material into alternative fuel sources |
| 07/22/2004 | US20040142454 Polynucleotides coding maltate dehydrogenase for use in transformation of microorganism and fermentive generation of lysine for medicines, foods and animal feeds/nutrients |
| 07/22/2004 | US20040142453 Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis |